Rene Paula Molina - 03 Nov 2023 Form 4 Insider Report for Vaxxinity, Inc.

Role
Officer
Signature
/s/ Rene Paula Molina
Issuer symbol
VAXX on OTC
Transactions as of
03 Nov 2023
Net transactions value
$0
Form type
4
Filing time
03 Nov 2023, 16:31:37 UTC
Previous filing
04 Apr 2023

Rene Paula Molina is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Mr. Paula Molina resigned effective November 3, 2023. His title was SVP, Legal & Business Affairs (General Counsel). As a result, Mr. Paula Molina is no longer subject to Section 16 of the Securities Exchange Act of 1934 in connection with his transactions in the equity securities of Vaxxinity, Inc. and, therefore, will no longer report any such transactions on Form 4 or Form 5.